主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MBRX
#4446
Moleculin Biotech, Inc.
2.040
0
USD
0.00%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
0.00%
每月变动
-35.24%
6个月变化
-35.24%
年变化
-35.24%
前一天收盘价
2.040
0
Open
2.020
0
Bid
2.040
0
Ask
2.043
0
Low
2.005
0
High
2.110
0
交易量
83
市场
股票
医疗保健
MBRX
Open full chart
Financials
Overview
声明
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
75.85 K
76.21 K
76.34 K
5 940.04
560.02 K
—
Valuation ratios
Enterprise value
—
—
—
—
-3.33 M
-23.31 M
Price to earnings ratio
—
—
—
—
-0.01
-0.01
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
-0.01
-0.03
Price to book ratio
—
—
—
—
0.04
0.08
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.6
0.19
0.51
0.78
1.29
2.07
Return on equity %
0.98
0.2
0.56
1.14
3.64
155.71
Return on invested capital %
669.67
784.36
1 046.67
992.33
900.22
807.42
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.89
20.02
9.46
3.86
0.97
4.86
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
361.83
4 574.73
173.26
62.95
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
565.04
4 470.14
31.06
68.37
Net current asset value per share
—
—
597.76
4 987
37.71
82.6
Tangible book value per share
—
—
538.07
2 832.99
-37.53
-63.09
Working capital per share
—
—
534.58
3 693.42
-1.2
8.69
Book value per share
—
—
684.22
4 949.04
43.41
73.1
新闻
Moleculin Biotech releases CEO update on leukemia trial
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.54%
美国股市收低;截至收盘道琼斯工业平均指数下跌0.54%
Moleculin Biotech股价因权证行权协议暴跌
Moleculin Biotech stock plunges after warrant exercise agreement
Moleculin Biotech通过权证行权筹资830万美元
Moleculin Biotech raises $8.3 million through warrant exercise
Moleculin Biotech股价上涨,AML药物试验显示出令人鼓舞的结果
Moleculin Biotech stock rises as AML drug trial shows promising results
Moleculin公布关键AML治疗试验早期数据,结果令人鼓舞
Moleculin reports promising early data in pivotal AML treatment trial
Moleculin Biotech获日本关键专利后股价上涨